Index by author

01 December 2022; volume 60, issue 6

  1. Adcock, Ian M.

    1. Liu, Gang et al "Adverse roles of mast cell chymase-1 in COPD." European Respiratory Journal 60.6 (2022): 2101431. Web. 07 Oct. 2024.

  2. Ahmed, Sajjad

    1. Leong, Wei Yee et al "Reference equations for evaluation of spirometry function tests in South Asia, and among South Asians living in other countries." European Respiratory Journal 60.6 (2022): 2102962. Web. 07 Oct. 2024.

  3. Akkerman, Onno W.

    1. Ghimire, Samiksha et al "Combining digital adherence technology and therapeutic drug monitoring for personalised tuberculosis care." European Respiratory Journal 60.6 (2022): 2201690. Web. 07 Oct. 2024.

  4. Albaiceta, Guillermo M.

    1. López-Alonso, Inés, Antonio Fueyo, and Guillermo M. Albaiceta. "Reply to: Ventilation and tumour spread: still a pending matter." European Respiratory Journal 60.6 (2022): 2201826. Web. 07 Oct. 2024.

  5. Ali, Md Khadem

    1. Ali, Md Khadem et al "The role of circular RNAs in pulmonary hypertension." European Respiratory Journal 60.6 (2022): 2200012. Web. 07 Oct. 2024.

  6. Aman, Jurjan

    1. Aman, Jurjan et al "The SOX17 phenotype in pulmonary arterial hypertension: lessons for pathobiology and clinical management." European Respiratory Journal 60.6 (2022): 2201438. Web. 07 Oct. 2024.
    2. de Brabander, Justin et al "Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients." European Respiratory Journal 60.6 (2022): 2200780. Web. 07 Oct. 2024.

  7. Andersson, Lars I.

    1. Sparreman Mikus, Maria et al "Reply: U-BIOPRED/BIOAIR proteins: inflammation or infection?." European Respiratory Journal 60.6 (2022): 2201795. Web. 07 Oct. 2024.

  8. Ando, Masahiko

    1. Otsubo, Kohei et al "Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial." European Respiratory Journal 60.6 (2022): 2200380. Web. 07 Oct. 2024.

  9. Atagi, Shinji

    1. Otsubo, Kohei et al "Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial." European Respiratory Journal 60.6 (2022): 2200380. Web. 07 Oct. 2024.

  10. Balachandran, Sharaniyaa

    1. Husain, Shahid et al "A biomarker assay to risk-stratify patients with symptoms of respiratory tract infection." European Respiratory Journal 60.6 (2022): 2200459. Web. 07 Oct. 2024.
« Previous (Pages : 1 2 3 4 5 6 ... 48) Next »
Back to top
European Respiratory Journal: 60 (6)

Search Within This Issue

Jump to

Manage Table of content Alerts